Skip to content
healthcare.dev

Buscapina

NDC 69729-813, Acetaminophen, Caffeine and Pyrilamine Maleate, tablet, film coated, from OPMX LLC.

Product NDC
69729-813
Status
Listed
Labeler
OPMX LLC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M013
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69729-813 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PYRILAMINE MALEATE500 mg/1
  • ACETAMINOPHEN500 mg/1
  • CAFFEINE60 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Methylxanthine [EPC]; Xanthines [CS]

Package NDCNDC-11Package
69729-813-24697290813242 BLISTER PACK in 1 CARTON (69729-813-24) / 12 TABLET, FILM COATED in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 69729-813 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69729-813 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69729-813. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.